Product
Ferric Pyrophosphate Liposomal
2 clinical trials
2 indications
Indication
Anemia, NutritionalIndication
CKD - Chronic Kidney DiseaseClinical trial
Effect of Ferrous Ascorbate Versus Liposomal Iron on Hemoglobin Concentration and Iron Indices in 6 to 59 Months Age Children With Nutritional Iron-Deficiency Anemia: A Double-blinded Single Centre Randomized Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2024-08-01
Clinical trial
Comparative Clinical Study to Evaluate the Efficacy and Safety of Oral Liposomal Iron, Oral Iron Supported Lactoferrin and IV Iron Dextran in Children With Chronic Kidney DiseaseStatus: Not yet recruiting, Estimated PCD: 2024-01-01